These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24641563)

  • 1. High-content analysis in toxicology: screening substances for human toxicity potential, elucidating subcellular mechanisms and in vivo use as translational safety biomarkers.
    O'Brien PJ
    Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):4-17. PubMed ID: 24641563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
    O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
    Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation of novel anti-cancer cytotoxicity biomarkers detected with high content analysis from an in vitro predictive model to an in vivo cell model.
    Lieggi NT; Edvardsson A; O'Brien PJ
    Toxicol In Vitro; 2010 Dec; 24(8):2063-71. PubMed ID: 20670680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes.
    Nadanaciva S; Aleo MD; Strock CJ; Stedman DB; Wang H; Will Y
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):272-80. PubMed ID: 23811329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening.
    Palmer JA; Smith AM; Egnash LA; Conard KR; West PR; Burrier RE; Donley EL; Kirchner FR
    Birth Defects Res B Dev Reprod Toxicol; 2013 Aug; 98(4):343-63. PubMed ID: 24123775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term chronic toxicity testing using human pluripotent stem cell-derived hepatocytes.
    Holmgren G; Sjögren AK; Barragan I; Sabirsh A; Sartipy P; Synnergren J; Björquist P; Ingelman-Sundberg M; Andersson TB; Edsbagge J
    Drug Metab Dispos; 2014 Sep; 42(9):1401-6. PubMed ID: 24980256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aroclor 1254 induced cytotoxicity and mitochondrial dysfunction in isolated rat hepatocytes.
    Aly HA; Domènech O
    Toxicology; 2009 Aug; 262(3):175-83. PubMed ID: 19486918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a high-content multiparameter cytotoxicity assay to prioritize compounds based on toxicity potential in humans.
    Abraham VC; Towne DL; Waring JF; Warrior U; Burns DJ
    J Biomol Screen; 2008 Jul; 13(6):527-37. PubMed ID: 18566484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of potential hepatotoxicity induced by drugs.
    Gómez-Lechón MJ; Lahoz A; Gombau L; Castell JV; Donato MT
    Curr Pharm Des; 2010 Jun; 16(17):1963-77. PubMed ID: 20236064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high content screening assay to predict human drug-induced liver injury during drug discovery.
    Persson M; Løye AF; Mow T; Hornberg JJ
    J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development.
    Thompson RA; Isin EM; Li Y; Weaver R; Weidolf L; Wilson I; Claesson A; Page K; Dolgos H; Kenna JG
    Chem Biol Interact; 2011 Jun; 192(1-2):65-71. PubMed ID: 21074519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of hepatocytes to investigate drug toxicity.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Methods Mol Biol; 2010; 640():389-415. PubMed ID: 20645064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved.
    Tolosa L; Gómez-Lechón MJ; Pérez-Cataldo G; Castell JV; Donato MT
    Arch Toxicol; 2013 Jun; 87(6):1115-27. PubMed ID: 23397584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment.
    Wetmore BA; Wambaugh JF; Ferguson SS; Sochaski MA; Rotroff DM; Freeman K; Clewell HJ; Dix DJ; Andersen ME; Houck KA; Allen B; Judson RS; Singh R; Kavlock RJ; Richard AM; Thomas RS
    Toxicol Sci; 2012 Jan; 125(1):157-74. PubMed ID: 21948869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of apoptotic drugs: multiparametric evaluation in cultured hepatocytes.
    Gómez-Lechón MJ; O'Connor JE; Lahoz A; Castell JV; Donato MT
    Curr Med Chem; 2008; 15(20):2071-85. PubMed ID: 18691057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test systems in drug discovery for hazard identification and risk assessment of human drug-induced liver injury.
    Weaver RJ; Betts C; Blomme EAG; Gerets HHJ; Gjervig Jensen K; Hewitt PG; Juhila S; Labbe G; Liguori MJ; Mesens N; Ogese MO; Persson M; Snoeys J; Stevens JL; Walker T; Park BK
    Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):767-782. PubMed ID: 28604124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro gene expression analysis of hepatotoxic drugs in rat primary hepatocytes.
    Suzuki H; Inoue T; Matsushita T; Kobayashi K; Horii I; Hirabayashi Y; Inoue T
    J Appl Toxicol; 2008 Mar; 28(2):227-36. PubMed ID: 18246545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential.
    Xu JJ; Diaz D; O'Brien PJ
    Chem Biol Interact; 2004 Nov; 150(1):115-28. PubMed ID: 15522265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.